Breaking News Instant updates and real-time market news.

A

Agilent

$78.62

1.14 (1.47%)

16:06
02/20/19
02/20
16:06
02/20/19
16:06

Agilent reports Q1 EPS 76c, consensus 73c

Reports Q1 revenue $1.28B, consensus $1.27B. "We are pleased to start the year with a strong performance driving excellent revenue and EPS growth and exceeding our guidance. The Agilent team is delivering on our commitment to drive superior revenue and earnings growth," said Mike McMullen, Agilent president and CEO.

A Agilent
$78.62

1.14 (1.47%)

11/20/18
JPMS
11/20/18
NO CHANGE
Target $80
JPMS
Overweight
Agilent reported 'exceedingly strong quarter,' says JPMorgan
JPMorgan analyst Tycho Peterson says Agilent Technologies reported an "exceedingly strong quarter," with core growth of 9% "well above guidance and elevated expectations." The analyst continues to like the story and maintain an Overweight rating on the shares with an $80 price target. Heading into fiscal 2019 and beyond, Peterson continues to see "multiple drivers" to accelerate growth, including the Intuvo/Ultivo product cycles and accelerating momentum in biopharma.
01/02/19
NEED
01/02/19
INITIATION
Target $77
NEED
Buy
Agilent initiated with a Buy at Needham
Needham analyst Stephen Unger started Agilent Technologies with a Buy rating and $77 price target. The analyst sees "significant potential" for ongoing earnings upside as the company leverages its "expanding portfolio" of advanced technologies.
01/03/19
BOFA
01/03/19
NO CHANGE
Target $78
BOFA
Buy
Agilent initial FY19 guidance looks conservative, says BofA/Merrill
BofA/Merrill Derik de Bruin kept his Buy rating and his $78 price target on Agilent but designated the stock as his top pick for 2019 as part of his broader research note on Life Sciences & Diagnostic Tools. The analyst notes that while the Life Science Tool sector valuations remain at a premium relative to the S&P500 and most other healthcare sub-sectors, the gap has narrowed as organic growth slowed to just over 6%. de Bruin sees sector growth moderating further to 5% because of tough comps in 2019, but he is also positive on the industry's long-term positioning to "to reduce cyclical exposure and increase the level of recurring revenues." The analyst is especially positive on Agilent, where valuations have compressed from 28-times to 20-times earnings because of its "higher than average exposure to chemical and energy customers, concerns over China and trade, and cheaper opportunities elsewhere in the sector", but he sees the company's portfolio becoming much less cyclical today.
02/12/19
DBAB
02/12/19
NO CHANGE
Target $85
DBAB
Buy
Agilent price target raised to $85 from $80 at Deutsche Bank
Deutsche Bank analyst Dan Leonard raised his price target for Agilent Technologies to $85 citing a roll-forward of his valuation methodology by one quarter. The analyst believes Agilent has more opportunities for growth, margin expansion, and capital deployment than peers. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

TELDF

Telefonica Deutschland

$0.00

(0.00%)

05:27
09/23/19
09/23
05:27
09/23/19
05:27
Upgrade
Telefonica Deutschland rating change  »

Telefonica Deutschland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGY

VAALCO Energy

$2.08

0.06 (2.97%)

05:26
09/23/19
09/23
05:26
09/23/19
05:26
Initiation
VAALCO Energy initiated  »

VAALCO Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$11.64

-0.565 (-4.63%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Hot Stocks
PG&E expects to turn off power late Monday in nine CA counties due to fire risk »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Oct

  • 10

    Nov

  • 10

    Nov

  • 07

    Jan

AIBRF

AIB Group

$0.00

(0.00%)

05:25
09/23/19
09/23
05:25
09/23/19
05:25
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAOFY

Tatneft

$0.00

(0.00%)

05:22
09/23/19
09/23
05:22
09/23/19
05:22
Downgrade
Tatneft rating change  »

Tatneft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:21
09/23/19
09/23
05:21
09/23/19
05:21
Upgrade
easyJet rating change  »

easyJet upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLOWY

Vallourec

$0.00

(0.00%)

05:20
09/23/19
09/23
05:20
09/23/19
05:20
Downgrade
Vallourec rating change  »

Vallourec downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELNY

Telenor

$0.00

(0.00%)

05:15
09/23/19
09/23
05:15
09/23/19
05:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANNSF

Aena

$0.00

(0.00%)

05:14
09/23/19
09/23
05:14
09/23/19
05:14
Downgrade
Aena rating change  »

Aena downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

05:13
09/23/19
09/23
05:13
09/23/19
05:13
Recommendations
Apple analyst commentary  »

Piper survey shows higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$154.45

-0.49 (-0.32%)

, ABT

Abbott

$83.56

0.35 (0.42%)

05:04
09/23/19
09/23
05:04
09/23/19
05:04
Recommendations
DexCom, Abbott analyst commentary  »

DexCom remains a…

DXCM

DexCom

$154.45

-0.49 (-0.32%)

ABT

Abbott

$83.56

0.35 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

  • 13

    Nov

EW

Edwards Lifesciences

$219.56

4.45 (2.07%)

04:58
09/23/19
09/23
04:58
09/23/19
04:58
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

, HON

Honeywell

$168.42

1.7 (1.02%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Downgrade
Illinois Tool Works, Honeywell rating change  »

Illinois Tool Works…

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

HON

Honeywell

$168.42

1.7 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HR

Healthcare Realty Trust

$33.17

-0.155 (-0.47%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Healthcare Realty Trust management to meet with Capital One »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

NBIX

Neurocrine

$100.74

-0.77 (-0.76%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Neurocrine participates in a conference call with JPMorgan »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SIBN

SI-Bone

$20.18

0.28 (1.41%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
SI-Bone management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Texas Instruments management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLDR

Cloudera

$9.00

0.33 (3.81%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Cloudera management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

IMAX

Imax

$21.83

0.04 (0.18%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Recommendations
Imax analyst commentary  »

Imax management to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

KNSL

Kinsale Capital Group

$99.46

-1.68 (-1.66%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Kinsale Capital Group management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

September PMI Composite…

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

HKMPY

Hikma

$0.00

(0.00%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Hikma participates in a conference call with JPMorgan »

European Pharma Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 25

    Sep

DNOW

NOW Inc.

$12.05

-0.055 (-0.45%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
NOW Inc. management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 06

    Nov

  • 11

    Nov

  • 12

    Nov

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.